SCHEMBL4771223

SCHEMBL4771223

[CH2][C@H](C(=O)OC)c1ccc(O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.54
ESR2 Q92731 3/20 0.54
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA7 P43166 2/20 0.45
CA9 Q16790 2/20 0.45
CA14 Q9ULX7 2/20 0.45
MMP2 P08253 1/20 0.45
MMP9 P14780 1/20 0.45
MMP13 P45452 1/20 0.45
KMT2A Q03164 1/20 0.42
MIF P14174 3/20 0.41
PDCD1 Q15116 1/20 0.41
CD274 Q9NZQ7 1/20 0.41
TYR P14679 1/20 0.39
ESRRB O95718 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MDM4 O15151 1/20 0.38
MDM2 Q00987 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4767023 1.00 ESR1 (0.54) ESR1ESR2CA12CA1CA2
SCHEMBL27662344 1.00 ESR1 (0.54) ESR1ESR2CA12CA1CA2
SCHEMBL4769469 0.82 KMT2A (0.64) KMT2AALDH1A1
SCHEMBL295570 0.82 KMT2A (0.64) KMT2AALDH1A1
SCHEMBL4764549 0.82 KMT2A (0.64) KMT2AALDH1A1
SCHEMBL4764326 0.81 CA12 (0.52) ESR1ESR2CA12CA1CA2
SCHEMBL4766810 0.79 MIF (0.40) ESR1ESR2CA12CA1CA2
SCHEMBL384968 0.79 ESR1 (0.58) ESR1ESR2CA12CA1CA2
SCHEMBL8406161 0.79 ESR1 (0.58) ESR1ESR2CA12CA1CA2
SCHEMBL3205350 0.78 ESR1 (0.56) ESR1ESR2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1572678-A4 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS ELAN PHARM INC (US) 2008-05-07 EP claimed
EP-1572678-A2 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS Elan Pharmaceuticals, Inc. (US) 2005-09-14 EP claimed
WO-2004056319-A2 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS ELAN PHARMACEUTICALS INC. (US) 2004-07-08 WO claimed
EP-1572678-A4 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS ELAN PHARM INC (US) 2008-05-07 EP disclosed
EP-1572678-A2 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS Elan Pharmaceuticals, Inc. (US) 2005-09-14 EP disclosed
EP-1501807-A1 SULFONYLQUINOXALONE ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ ANTAGONISTS Elan Pharmaceuticals, Inc. (US) 2005-02-02 EP disclosed
WO-2004056319-A2 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS ELAN PHARMACEUTICALS INC. (US) 2004-07-08 WO disclosed
WO-2003093245-A1 SULFONYLQUINOXALONE ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ ANTAGONISTS ELAN PHARMACEUTICALS, INC. (US) 2003-11-13 WO disclosed